In 2026, the question is no longer whether artificial intelligence will transform medicine. It already has. The real question is now more nuanced: what can — and should — a doctor genuinely entrust to an AI, and what remains irreducibly human in the act of care?
The pressure is real. According to a study by France's DREES, administrative and documentation tasks consume between 25 and 35% of healthcare professionals' time. This time stolen from clinical work has a direct cost on care quality, caregiver burnout and patients' lives.
Galeon has been tackling this challenge since 2016. Present in 19 hospitals including 2 university medical centers, with over 3 million structured patient records and more than 10,000 caregivers on the platform, Galeon has built an infrastructure that allows medical AI to be genuinely useful - starting from clean, secure, and exploitable data.
This article examines what AI can truly do today, the tasks it cannot replace, and how a sovereign data infrastructure fundamentally changes the relevance of clinical algorithms.
The healthcare system is under structural strain. An aging medical workforce, an explosion in chronic diseases, and a growing administrative burden are creating an ever-widening gap between available time and actual patient needs.
This overload has consequences. A meta-analysis published in the British Medical Journal (2021) establishes a direct link between caregiver workload and the increase in unintentional medical errors. The WHO estimates that such errors represent the 3rd leading cause of death in developed countries - often not due to a lack of skills, but a lack of time and well-structured data.
AI is not here to replace the doctor. It is here to absorb low-value cognitive load so that physicians can focus on what matters: complex clinical decision-making, the therapeutic relationship, and empathy.
Artificial intelligence does not replace the doctor. It gives back time, the scarcest resource in any hospital.
Not all tasks are equal in the face of AI. Here are the domains where algorithms are reaching - or exceeding - human performance on measurable criteria.
Radiology is the field where AI has made the most documented progress. A study published in Nature Medicine (2020) by a Google Health team showed that their algorithms detected breast cancer with 9.4% fewer false positives than human radiologists, across a dataset of over 25,000 mammograms.
In practice, this translates into concrete gains:
AI does not sign the report. But it sorts, prioritizes, and flags critical scans - which, in an overworked radiology department, can make the difference between early detection and late diagnosis.
Medication errors are among the most frequent serious adverse events in hospital settings. They are often linked to cognitive overload at the time of prescribing, unfamiliarity with rare contraindications, or interactions within complex polypharmacy regimens.
AI integrated into the intelligent patient record can analyze in real time:
A prescription support algorithm does not decide in place of the doctor. It flags what the doctor might have missed under pressure.
This is one of the largest reservoirs of recoverable time. Transcribing consultations, drafting hospital discharge summaries, updating medical histories: these tasks consume a significant share of medical time without delivering direct clinical value.
Specialized medical language models (LLMs) are today capable of:
The non-negotiable prerequisite: data must be structured at the point of creation. This is precisely what Galeon's intelligent EHR does — every piece of data entered is normalized, validated by the caregiver, and immediately usable by algorithms.
In emergency departments and intensive care units, early prediction of clinical deterioration can save lives. Algorithms trained on millions of patient records are capable of identifying, several hours in advance, the early warning signs of sepsis, cardiac decompensation, or respiratory distress.
According to a study published in Nature (2019) conducted by DeepMind on 700,000 patients, an AI algorithm detected cases of acute kidney injury 48 hours before the first clinical signs appeared, in 90% of cases. This anticipation window is medically decisive.
AI excels at pattern recognition across volumes of data that humans cannot process. But it has deep, structural blind spots that are not going away anytime soon.
Doctors remain irreplaceable for :
An algorithm can predict that a patient has an 85% probability of having cancer. It cannot explain what that means for that person, for their family, or co-decide on a treatment strategy. That is the line AI will not cross.
AI diagnoses patterns. Doctors treat people. These two activities are not in competition : they are complementary.
The quality of a medical AI algorithm is directly proportional to the quality of the data it is trained on. This is the central paradox of AI in healthcare: medical data exists in abundance, but it is heterogeneous, poorly structured, and scattered across incompatible silos.
Galeon solves this problem at the source. Since 2016, the platform structures and normalizes medical data directly at the point of clinical entry — not in post-processing, not through extraction, but natively, by the caregivers themselves. The result: clean, standardized medical data that is immediately usable for algorithm training.
The Blockchain Swarm Learning® (BSL®), Galeon's proprietary technology, then enables AI models to be trained across the entire network's data — 19 hospitals, 3 million records — without that data ever leaving each institution's local servers.
Data never leaves the hospital's servers. This is the founding principle of Galeon's Blockchain Swarm Learning®.
Enthusiasm around AI in healthcare must not obscure real challenges. Here are the honest limitations to understand before any deployment.
An algorithm trained on unrepresentative data produces biased results. If training data under-represents certain populations (women, the elderly, ethnic minorities), predictions will be less reliable for those groups. Data source diversity is a central ethical issue, not a technical footnote.
In Europe, the regulatory framework is clear: medical decisions are the responsibility of the doctor, regardless of any algorithmic recommendation. AI is a decision-support tool, not a decision-maker. This distinction is fundamental in legal and deontological terms.
Caregivers must be able to understand why an algorithm makes a given recommendation. So-called "black box" systems, whose decisions are not explainable, generate legitimate distrust. Explainability (XAI) is a prerequisite for routine clinical deployment.
The European AI Act (in force since 2024) classifies medical AI devices as high-risk. This entails stricter obligations around transparency, auditing, and certification. Time-to-market can be significantly extended as a result.
The majority of hospital AI projects fail or underperform not because of the algorithms, but because of insufficiently structured data. Without upstream investment in the quality of clinical data, no algorithm can deliver on its promises.
Can AI make a diagnosis instead of a doctor ?
No : not legally and not clinically. European law is unambiguous: any diagnostic act is the responsibility of the physician. AI produces suggestions, probabilities, and alerts — the doctor decides. In practice, the best outcomes are achieved by combining AI analysis with human clinical judgment.
Which medical specialties benefit most from AI today ?
Radiology and anatomical pathology are the most advanced, followed by cardiology (arrhythmia detection on ECG), dermatology (skin lesion recognition), and emergency medicine (predictive triage). These disciplines share a common trait: visual or structured data available in volumes sufficient to train robust algorithms.
How can patient data confidentiality be guaranteed when used by AI ?
This is the central challenge. The standard approach involves anonymizing data before use, but this reduces its clinical value. Galeon's Blockchain Swarm Learning® takes a different approach: algorithms travel to the data — not the other way around. Data never leaves the hospital's servers, guaranteeing institutional sovereignty and patient privacy.
How long does it take to deploy a medical AI tool in a hospital ?
Timelines vary depending on the institution's data maturity, integration complexity, and regulatory requirements. For a straightforward prescription-support tool, deployment can be achieved within a few months. For an image-based diagnostic system, MDR certification can add 12 to 24 months. Hospitals already equipped with a structured EHR like Galeon's start with a significant advantage.
Will AI reduce medical staffing levels ?
Available research points in the opposite direction. Rather than eliminating positions, AI allows existing caregivers to manage more patients with better care quality. In the context of a structural medical shortage across Europe, most CIOs view AI as a productivity lever, not an employment threat.
What is Galeon's Blockchain Swarm Learning® (BSL®) ?
It is a proprietary technology that enables AI algorithms to be trained on data distributed across multiple hospitals, without that data ever leaving local servers. Galeon's blockchain traces every use of data, guarantees process transparency, and enables value generated to be redistributed to contributing hospitals — up to 40% per transaction. It is a sovereign alternative to the centralized architectures offered by big tech platforms.
Medical AI has delivered on several of its best-documented promises : imaging, early detection, prescription support, predictive triage. It remains a tool, not an oracle. Its real value depends on a fundamental condition that many actors still underestimate : the quality and structure of upstream data. Without clean, normalized, and exploitable medical data, even the most sophisticated algorithms will underperform.
This is precisely the work Galeon began in 2016: building a sovereign, decentralized medical data infrastructure designed for AI from the ground up. With 19 hospitals, 3 million structured patient records, and a proprietary technology for secure inter-hospital data sharing, Galeon represents an approach that reconciles clinical ambition with ethical requirements.
The medicine of tomorrow will not be a medicine without doctors. It will be a medicine where every caregiver finally has the time and information needed to truly heal.




